EMA proposes revamping COVID-19 vaccine guidance for the post-pandemic era
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCoronavirus/COVID-19EuropePharmaceuticalsPharmacovigilancePostmarketing requirement/postmarketing commitmentProduct LifecycleRegulatory Intelligence/Policy